1 of
4
Welcoming great ideas,
every day.
We help innovators bring their ideas to market.
1 of 8
Welcoming great ideas,
every day.
We help innovators bring their ideas to market.

InheRET: Finding At-Risk People Before They Become Cancer Patients

U-M’s Kelly Sexton – Preserve Innovation at Michigan’s Research Universities

University Collaboration with DoD Aims to Strengthen National Security, Spur Technologies

MTRAC Transportation Names New Commercialization Program Director

Praktio – Helping Lawyers Learn through Mistakes

University Startup Efforts Push Forward as New Capital Comes Available

U-M’s Kelly Sexton: Biotech Industry Continues to Thrive, Find New Solutions

Courage Therapeutics

Educational Series: Startup 101 Webinars

U-M Startup Oncopia Acquired by Roivant

InheRET: Finding At-Risk People Before They Become Cancer Patients

U-M’s Kelly Sexton – Preserve Innovation at Michigan’s Research Universities

University Collaboration with DoD Aims to Strengthen National Security, Spur Technologies

MTRAC Transportation Names New Commercialization Program Director

Praktio – Helping Lawyers Learn through Mistakes

University Startup Efforts Push Forward as New Capital Comes Available

U-M’s Kelly Sexton: Biotech Industry Continues to Thrive, Find New Solutions

Courage Therapeutics

Educational Series: Startup 101 Webinars

U-M Startup Oncopia Acquired by Roivant

InheRET: Finding At-Risk People Before They Become Cancer Patients

U-M’s Kelly Sexton – Preserve Innovation at Michigan’s Research Universities

University Collaboration with DoD Aims to Strengthen National Security, Spur Technologies

MTRAC Transportation Names New Commercialization Program Director

Praktio – Helping Lawyers Learn through Mistakes

University Startup Efforts Push Forward as New Capital Comes Available

U-M’s Kelly Sexton: Biotech Industry Continues to Thrive, Find New Solutions

Courage Therapeutics

Educational Series: Startup 101 Webinars

U-M Startup Oncopia Acquired by Roivant

InheRET: Finding At-Risk People Before They Become Cancer Patients

U-M’s Kelly Sexton – Preserve Innovation at Michigan’s Research Universities

University Collaboration with DoD Aims to Strengthen National Security, Spur Technologies

MTRAC Transportation Names New Commercialization Program Director

Praktio – Helping Lawyers Learn through Mistakes

University Startup Efforts Push Forward as New Capital Comes Available

U-M’s Kelly Sexton: Biotech Industry Continues to Thrive, Find New Solutions

Courage Therapeutics

Educational Series: Startup 101 Webinars

U-M Startup Oncopia Acquired by Roivant

InheRET: Finding At-Risk People Before They Become Cancer Patients

U-M’s Kelly Sexton – Preserve Innovation at Michigan’s Research Universities

University Collaboration with DoD Aims to Strengthen National Security, Spur Technologies

MTRAC Transportation Names New Commercialization Program Director

Praktio – Helping Lawyers Learn through Mistakes

University Startup Efforts Push Forward as New Capital Comes Available

U-M’s Kelly Sexton: Biotech Industry Continues to Thrive, Find New Solutions

Courage Therapeutics

Educational Series: Startup 101 Webinars

U-M Startup Oncopia Acquired by Roivant

InheRET: Finding At-Risk People Before They Become Cancer Patients

U-M’s Kelly Sexton – Preserve Innovation at Michigan’s Research Universities

University Collaboration with DoD Aims to Strengthen National Security, Spur Technologies

MTRAC Transportation Names New Commercialization Program Director

Praktio – Helping Lawyers Learn through Mistakes

University Startup Efforts Push Forward as New Capital Comes Available

U-M’s Kelly Sexton: Biotech Industry Continues to Thrive, Find New Solutions

Courage Therapeutics

Educational Series: Startup 101 Webinars

U-M Startup Oncopia Acquired by Roivant

LATEST NEWS

May 2021 Newsletter

February 2021 Newsletter

November 2020 Newsletter

Impact Report 2020

June 2020 Newsletter

U-M Innovators' Fight Against COVID-19

April 2020 Newsletter

December 2019 Newsletter
FEATURED TECH
Pre-Equilibrium Single-Molecule Digital Counting of Immune Complex Formation: A Novel Method for Rapid, Sensitive Multiplex Immunoassay

Pre-Equilibrium Single-Molecule Digital Counting of Immune Complex Formation: A Novel Method for Rapid, Sensitive Multiplex Immunoassay
Technology #2019-323
Applications
  • High throughput screening for COVID-19 related infectionsFast, close to real-time monitoring of blood
  • biomarkers (e.g. to detect cytokine storm in COVID-19 patients, CART therapy recipients etc)
Advantages
  • High-throughput, highly accurate and cost-effective
  • Fully automated system limits human error
  • Best on the market turnover (<30 min)
  • Ability to multiplex
  • Adaptability to test for other infections, blood biomarkers etc.
  • Portable bench-top size enables use at high-traffic locations such as airports and other ports of entry
MORE
TWITTER